PCI Brexit Communication, 12th April 2019

The European Council and the UK Prime Minister have agreed and announced an extension to Article 50 with a flexible Brexit delay until 31st October 2019, with a review at the end of June. However, the UK will be able to leave the EU before this October date should a deal be agreed by UK […]

PCI Brexit Communication, 3rd April 2019

On the 29th March 2019, a vote took place on the proposed first stage of the renegotiated Brexit deal by the United Kingdom (UK) Parliament. The plan was subsequently rejected and as a result, the extended deadline agreed during the EU Summit on the 21st March 2019 for the UK to leave the European Union […]

Expansion of High Potent Tableting and Powder Modification Capacity

Investment in new technologies at PCI’s global manufacturing Center of Excellence in Tredegar, Wales, to double highly potent tableting capacity and boost powder handling capability We are pleased to announce further investment to expand our flagship manufacturing center in Tredegar, Wales. The investment at Tredegar will double our highly potent tableting capacity and see an […]

PCI Welcomes New Chief Financial Officer and SVP, Serge Dupuis

PCI is pleased to welcome Serge Dupuis as Senior Vice President and Chief Financial Officer. Serge’s appointment supports PCI’s continued strategic growth and expansion across global network, currently spanning 20 facilities in eight locations across three continents. PCI features a broad portfolio of outsourced development and commercialization services focused in drug development and manufacturing, clinical […]

Jeremy Osborne to Share his Expertise on Accelerating into Early Clinical Trials

PCI will share our specialist clinical trials expertise at the upcoming Clinical Trial Supply New England Conference. PCI’s Jeremy Osborne, Manager of Project Management, will take to the stage on Tuesday, March 26 at 9am EST, with his presentation ‘Accelerating into Early Clinical Trials with Speed and Flexibility’. Jeremy will discuss how to create solutions […]

Lisa Spence Appointed as Director of Clinical Supply Chain – International Region

PCI Clinical Services is pleased to announce the appointment of Lisa Spence as Director of Clinical Supply Chain for our International region. Based out of the UK, Lisa will partner with Katy Ostertag-Johnson, Director of Clinical Supply Chain, North America, to build and lead the expansion of PCI’s SMART Supply Management team, providing a harmonized […]

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Your bridge between life-changing therapies and patients